Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 23049696)

1.

VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity.

Rao M, Song W, Jiang A, Shyr Y, Lev S, Greenstein D, Brantley-Sieders D, Chen J.

PLoS One. 2012;7(10):e46281. doi: 10.1371/journal.pone.0046281. Epub 2012 Oct 1.

2.

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.

Banerjee A, Wu ZS, Qian P, Kang J, Pandey V, Liu DX, Zhu T, Lobie PE.

Breast Cancer Res. 2011;13(6):R112. doi: 10.1186/bcr3054. Epub 2011 Nov 7.

3.

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

Cancer Res. 2006 May 1;66(9):4672-80.

4.

GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.

Bai T, Luoh SW.

Carcinogenesis. 2008 Mar;29(3):473-9. Epub 2007 Oct 4.

5.

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.

Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D.

Breast Cancer Res. 2012 Feb 21;14(1):R35.

6.

Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells.

Zhou NN, Tang J, Chen WD, Feng GK, Xie BF, Liu ZC, Yang D, Zhu XF.

Life Sci. 2012 May 22;90(19-20):770-5. doi: 10.1016/j.lfs.2012.03.035. Epub 2012 Apr 13.

PMID:
22525372
7.

IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase.

Weber GF, Gaertner FC, Erl W, Janssen KP, Blechert B, Holzmann B, Weighardt H, Essler M.

J Immunol. 2006 Dec 1;177(11):8266-72.

9.
10.

PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation.

Shahaf G, Rotem-Dai N, Koifman G, Raveh-Amit H, Frost SA, Livneh E.

Exp Cell Res. 2012 Apr 15;318(7):789-99. doi: 10.1016/j.yexcr.2012.01.018. Epub 2012 Jan 28.

PMID:
22305966
12.

Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines.

Nicholson KM, Streuli CH, Anderson NG.

Breast Cancer Res Treat. 2003 Sep;81(2):117-28.

PMID:
14572154
13.

Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.

Wang XY, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H, Glazer RI.

Mol Cancer. 2010 Aug 21;9:221. doi: 10.1186/1476-4598-9-221.

14.

t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer.

Vangamudi B, Peng DF, Cai Q, El-Rifai W, Zheng W, Belkhiri A.

Mol Cancer. 2010 Sep 13;9:240. doi: 10.1186/1476-4598-9-240.

15.

Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.

Lofgren KA, Ostrander JH, Housa D, Hubbard GK, Locatelli A, Bliss RL, Schwertfeger KL, Lange CA.

Breast Cancer Res. 2011 Sep 17;13(5):R89. doi: 10.1186/bcr2946.

16.

Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.

Yu W, Chai H, Li Y, Zhao H, Xie X, Zheng H, Wang C, Wang X, Yang G, Cai X, Falck JR, Yang J.

Toxicol Appl Pharmacol. 2012 Oct 1;264(1):73-83. doi: 10.1016/j.taap.2012.07.019. Epub 2012 Jul 25.

17.

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

Yao W, Feng D, Bian W, Yang L, Li Y, Yang Z, Xiong Y, Zheng J, Zhai R, He J.

Amino Acids. 2012 Nov;43(5):2027-35. doi: 10.1007/s00726-012-1277-z. Epub 2012 Apr 4.

18.

Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer.

Liu YP, Liao WC, Ger LP, Chen JC, Hsu TI, Lee YC, Chang HT, Chen YC, Jan YH, Lee KH, Zeng YH, Hsiao M, Lu PJ.

Cancer Res. 2013 Oct 15;73(20):6194-205. doi: 10.1158/0008-5472.CAN-13-0518. Epub 2013 Aug 13.

19.

Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility.

Pecorari L, Marin O, Silvestri C, Candini O, Rossi E, Guerzoni C, Cattelani S, Mariani SA, Corradini F, Ferrari-Amorotti G, Cortesi L, Bussolari R, Raschellà G, Federico MR, Calabretta B.

Mol Cancer. 2009 Aug 3;8:58. doi: 10.1186/1476-4598-8-58.

20.

Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.

Syed Khaja AS, Dizeyi N, Kopparapu PK, Anagnostaki L, Härkönen P, Persson JL.

PLoS One. 2013 Aug 8;8(8):e72210. doi: 10.1371/journal.pone.0072210. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk